Literature DB >> 30242043

Tobacco-specific nitrosamines (TSNA) in heated tobacco product IQOS.

Noel J Leigh1, Mary N Palumbo1, Anthony M Marino1, Richard J O'Connor1, Maciej Lukasz Goniewicz1.   

Abstract

Entities:  

Keywords:  electronic nicotine delivery devices; non-cigarette tobacco products

Mesh:

Substances:

Year:  2018        PMID: 30242043      PMCID: PMC6252482          DOI: 10.1136/tobaccocontrol-2018-054318

Source DB:  PubMed          Journal:  Tob Control        ISSN: 0964-4563            Impact factor:   7.552


× No keyword cloud information.

Background

Heated tobacco products (HTP) have an electrical heating component, like e-cigarettes, that heats processed tobacco to 350°C releasing volatile components that often are not detectable in e-cigarettes.1 Although many combustion by-products may be eliminated in HTP devices, nitrosamines are generated in the process of tobacco curing rather than during combustion, and may be transferred from the HTP into the aerosol that it generates.2–4 We hypothesised that HTP may be a significant source of tobacco-specific nitrosamines (TSNA). This pilot study determined TSNA yields in aerosol emitted from HTP in comparison to the electronic and tobacco cigarettes.

Methods

HTP (IQOS; Amber, tobacco flavour), e-cigarettes (MarkTen; 3.5% nicotine, tobacco flavoured) and tobacco cigarettes (Marlboro Red 100) were tested using a Borgwaldt LX-1 smoking machine following the Health Canada Intense protocol (55 mL puff volume, 2 s duration, 30 s interval). Using this puffing protocol, we generated aerosol from a single HTP HeatStick (12 puffs), single tobacco cigarette (8 puffs) and from e-cigarette (55 puffs). We used different number of puffs for each product to achieve a comparable nicotine delivery across all tested products. Cambridge filters (44 mm) were used to capture the total particulate matter from all tested products. The control samples (blanks) were generated by passing 55 puffs of air through the filter. Cambridge filters were spiked with deuterated internal standards and extracted using 20 mL 100 mM ammonium acetate. The following TSNAs were measured using liquid chromatography-tandem mass spectrometry: N'-nitrosoanabasine, N'-nitrosoanatabine, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) and N'-nitrosonornicotine (Toronto Research Chemicals; Canada).5 A limit of quantitation for each compound was 0.5 ng/filter. Nicotine was measured using gas chromatography with nitrogen-phosphorous detector (GC-NPD) method as described previously.6 Each product was tested in triplicate. The average TSNA yields for each product were calculated per single puff and per puffing session. We used analysis of variance to test for statistical differences between the three tested products and t-tests to compare TSNA yields from HTP with yields detected in e-cigarettes and combustible cigarettes.

Results

All four TSNA compounds analysed were detected in the HTP. The yields of individual TSNA per puff in the HTP aerosols were 8–22 times lower than in tobacco cigarette smoke (figure 1; all p<0.05). HTP delivered 1.4±0.2 mg nicotine from a single HeatStick (12 puffs); e-cigarette 1.3±0.2 mg per 55 puffs; and a single combustible cigarette 2.1±0.1 mg (8 puffs). TSNA yields normalised per nicotine delivery were also significantly higher in the HTP than those found in e-cigarettes and significantly lower than those found in tobacco cigarettes, except for NNK (p<0.05). TSNA yields in a single tobacco cigarette were between 7 and 17 times higher than TSNA yields in a single HTP HeatStick. No TSNAs were detected in the air control samples.
Figure 1

Yields of tobacco-specific nitrosamines (TSNA) (per puff) in aerosols generated from IQOS heated tobacco product (12 puffs/HeatStick), MarkTen e-cigarette (55 puffs) and smoke from Marlboro Red 100 combustible cigarettes (8 puffs/cigarette). The data presented are log transformed. LOQ, limit of quantitation; NAB, N'-nitrosoanabasine; NAT, N'-nitrosoanatabine; NNK, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone; NNN, N'-nitrosonornicotine.

Yields of tobacco-specific nitrosamines (TSNA) (per puff) in aerosols generated from IQOS heated tobacco product (12 puffs/HeatStick), MarkTen e-cigarette (55 puffs) and smoke from Marlboro Red 100 combustible cigarettes (8 puffs/cigarette). The data presented are log transformed. LOQ, limit of quantitation; NAB, N'-nitrosoanabasine; NAT, N'-nitrosoanatabine; NNK, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone; NNN, N'-nitrosonornicotine.

Conclusions

Like combustible products, HTPs emit substantial levels of carcinogenic TSNA. Although HTP emits lower amounts of TSNA than combustible cigarettes, the amounts are significantly higher than from e-cigarettes. Our findings are consistent with prior reports.3 4 7 One limitation of this study is that one puffing protocol was used for all devices. While this was helpful in comparing TSNA and nicotine delivery between devices, machine-based measurements are not represented of human smoking patterns or constitute intake.8 9 The tested HTP does not reduce emissions of an important class of tobacco carcinogens to the same degree as other commercially available technologies.
  8 in total

Review 1.  Biochemistry, biology, and carcinogenicity of tobacco-specific N-nitrosamines.

Authors:  S S Hecht
Journal:  Chem Res Toxicol       Date:  1998-06       Impact factor: 3.739

2.  Nicotine levels in electronic cigarettes.

Authors:  Maciej L Goniewicz; Tomasz Kuma; Michal Gawron; Jakub Knysak; Leon Kosmider
Journal:  Nicotine Tob Res       Date:  2012-04-22       Impact factor: 4.244

3.  Evaluation of the Tobacco Heating System 2.2. Part 2: Chemical composition, genotoxicity, cytotoxicity, and physical properties of the aerosol.

Authors:  Jean-Pierre Schaller; Daniela Keller; Laurent Poget; Pascal Pratte; Etienne Kaelin; Damian McHugh; Gianluca Cudazzo; Daniel Smart; Anthony R Tricker; Lydia Gautier; Michel Yerly; Roger Reis Pires; Soazig Le Bouhellec; David Ghosh; Iris Hofer; Eva Garcia; Patrick Vanscheeuwijck; Serge Maeder
Journal:  Regul Toxicol Pharmacol       Date:  2016-10-06       Impact factor: 3.271

4.  Smoke composition and predicting relationships for international commercial cigarettes smoked with three machine-smoking conditions.

Authors:  M E Counts; M J Morton; S W Laffoon; R H Cox; P J Lipowicz
Journal:  Regul Toxicol Pharmacol       Date:  2005-01-26       Impact factor: 3.271

5.  Comparison of Chemicals in Mainstream Smoke in Heat-not-burn Tobacco and Combustion Cigarettes.

Authors:  Kanae Bekki; Yohei Inaba; Shigehisa Uchiyama; Naoki Kunugita
Journal:  J UOEH       Date:  2017

6.  Levels of selected carcinogens and toxicants in vapour from electronic cigarettes.

Authors:  Maciej Lukasz Goniewicz; Jakub Knysak; Michal Gawron; Leon Kosmider; Andrzej Sobczak; Jolanta Kurek; Adam Prokopowicz; Magdalena Jablonska-Czapla; Czeslawa Rosik-Dulewska; Christopher Havel; Peyton Jacob; Neal Benowitz
Journal:  Tob Control       Date:  2013-03-06       Impact factor: 7.552

7.  Assessment of an in vitro whole cigarette smoke exposure system: The Borgwaldt RM20S 8-syringe smoking machine.

Authors:  Jason Adamson; David Azzopardi; Graham Errington; Colin Dickens; John McAughey; Marianna D Gaça
Journal:  Chem Cent J       Date:  2011-08-26       Impact factor: 4.215

8.  IQOS: examination of Philip Morris International's claim of reduced exposure.

Authors:  Gideon St Helen; Peyton Jacob Iii; Natalie Nardone; Neal L Benowitz
Journal:  Tob Control       Date:  2018-08-29       Impact factor: 7.552

  8 in total
  22 in total

1.  'It's like if a vape pen and a cigarette had a baby': a mixed methods study of perceptions and use of IQOS among US young adults.

Authors:  Zongshuan Duan; Daisy Le; Annie C Ciceron; Ruth Dickey-Chasins; Christina N Wysota; Yael Bar-Zeev; Hagai Levine; Lorien C Abroms; Katelyn F Romm; Carla J Berg
Journal:  Health Educ Res       Date:  2022-09-23

2.  Characterizing Heated Tobacco Product Use Among Adult Cigarette Smokers and Nicotine Vaping Product Users in the 2018 ITC Four Country Smoking & Vaping Survey.

Authors:  Connor R Miller; Edward Sutanto; Danielle M Smith; Sara C Hitchman; Shannon Gravely; Hua-Hie Yong; Ron Borland; Richard J O'Connor; K Michael Cummings; Geoffrey T Fong; Andrew Hyland; Anne C K Quah; Maciej L Goniewicz
Journal:  Nicotine Tob Res       Date:  2022-03-01       Impact factor: 5.825

3.  Acute effects of JUUL and IQOS in cigarette smokers.

Authors:  Sarah Maloney; Alisha Eversole; Melanie Crabtree; Eric Soule; Thomas Eissenberg; Alison Breland
Journal:  Tob Control       Date:  2020-02-10       Impact factor: 7.552

4.  Correlates of Awareness and Use of Heated Tobacco Products in a Sample of US Young Adults in 2018-2019.

Authors:  Michael S Dunbar; Rachana Seelam; Joan S Tucker; Anthony Rodriguez; Regina A Shih; Elizabeth J D'Amico
Journal:  Nicotine Tob Res       Date:  2020-12-12       Impact factor: 4.244

5.  Acute Effects of Heated Tobacco Product (IQOS) Aerosol Inhalation on Lung Tissue Damage and Inflammatory Changes in the Lungs.

Authors:  Tariq A Bhat; Suresh G Kalathil; Noel Leigh; Thivanka Muthumalage; Irfan Rahman; Maciej L Goniewicz; Yasmin M Thanavala
Journal:  Nicotine Tob Res       Date:  2021-06-08       Impact factor: 4.244

Review 6.  The effect of emerging tobacco related products and their toxic constituents on thrombosis.

Authors:  Ahmed B Alarabi; Patricia A Lozano; Fadi T Khasawneh; Fatima Z Alshbool
Journal:  Life Sci       Date:  2021-12-23       Impact factor: 6.780

7.  Informing iQOS Regulations in the United States: A Synthesis of What We Know.

Authors:  Carla J Berg; Yael Bar-Zeev; Hagai Levine
Journal:  Sage Open       Date:  2020-01-09

8.  Heated tobacco product regulation under US law and the FCTC.

Authors:  Lauren Kass Lempert; Stanton A Glantz
Journal:  Tob Control       Date:  2018-10-05       Impact factor: 7.552

9.  Heated tobacco products: another tobacco industry global strategy to slow progress in tobacco control.

Authors:  Stella A Bialous; Stanton A Glantz
Journal:  Tob Control       Date:  2018-09-12       Impact factor: 7.552

10.  Cytotoxic effects of heated tobacco products (HTP) on human bronchial epithelial cells.

Authors:  Noel J Leigh; Phillip L Tran; Richard J O'Connor; Maciej Lukasz Goniewicz
Journal:  Tob Control       Date:  2018-09-05       Impact factor: 7.552

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.